IBDEI1XL ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,30848,2)
;;=^5063033
;;^UTILITY(U,$J,358.3,30849,0)
;;=N17.0^^123^1596^3
;;^UTILITY(U,$J,358.3,30849,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30849,1,3,0)
;;=3^AKI w/ Tubular Necrosis
;;^UTILITY(U,$J,358.3,30849,1,4,0)
;;=4^N17.0
;;^UTILITY(U,$J,358.3,30849,2)
;;=^5015598
;;^UTILITY(U,$J,358.3,30850,0)
;;=N17.1^^123^1596^1
;;^UTILITY(U,$J,358.3,30850,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30850,1,3,0)
;;=3^AKI w/ Acute Cortical Necrosis
;;^UTILITY(U,$J,358.3,30850,1,4,0)
;;=4^N17.1
;;^UTILITY(U,$J,358.3,30850,2)
;;=^5015599
;;^UTILITY(U,$J,358.3,30851,0)
;;=N17.2^^123^1596^2
;;^UTILITY(U,$J,358.3,30851,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30851,1,3,0)
;;=3^AKI w/ Medullary Necrosis
;;^UTILITY(U,$J,358.3,30851,1,4,0)
;;=4^N17.2
;;^UTILITY(U,$J,358.3,30851,2)
;;=^5015600
;;^UTILITY(U,$J,358.3,30852,0)
;;=N10.^^123^1596^6
;;^UTILITY(U,$J,358.3,30852,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30852,1,3,0)
;;=3^Acute Tubulo-Interstitial Nephritis
;;^UTILITY(U,$J,358.3,30852,1,4,0)
;;=4^N10.
;;^UTILITY(U,$J,358.3,30852,2)
;;=^5015570
;;^UTILITY(U,$J,358.3,30853,0)
;;=N17.8^^123^1596^4
;;^UTILITY(U,$J,358.3,30853,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30853,1,3,0)
;;=3^AKI,Other
;;^UTILITY(U,$J,358.3,30853,1,4,0)
;;=4^N17.8
;;^UTILITY(U,$J,358.3,30853,2)
;;=^5015601
;;^UTILITY(U,$J,358.3,30854,0)
;;=N17.9^^123^1596^5
;;^UTILITY(U,$J,358.3,30854,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30854,1,3,0)
;;=3^AKI,Unspec
;;^UTILITY(U,$J,358.3,30854,1,4,0)
;;=4^N17.9
;;^UTILITY(U,$J,358.3,30854,2)
;;=^338532
;;^UTILITY(U,$J,358.3,30855,0)
;;=R39.2^^123^1596^15
;;^UTILITY(U,$J,358.3,30855,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30855,1,3,0)
;;=3^Pre-Renal Uremia
;;^UTILITY(U,$J,358.3,30855,1,4,0)
;;=4^R39.2
;;^UTILITY(U,$J,358.3,30855,2)
;;=^5019348
;;^UTILITY(U,$J,358.3,30856,0)
;;=N13.9^^123^1596^14
;;^UTILITY(U,$J,358.3,30856,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30856,1,3,0)
;;=3^Obstructive and Reflux Uropathy,Unspec
;;^UTILITY(U,$J,358.3,30856,1,4,0)
;;=4^N13.9
;;^UTILITY(U,$J,358.3,30856,2)
;;=^5015589
;;^UTILITY(U,$J,358.3,30857,0)
;;=N13.1^^123^1596^11
;;^UTILITY(U,$J,358.3,30857,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30857,1,3,0)
;;=3^Hydronephrosis w/ Ureteral Stricture NEC
;;^UTILITY(U,$J,358.3,30857,1,4,0)
;;=4^N13.1
;;^UTILITY(U,$J,358.3,30857,2)
;;=^5015576
;;^UTILITY(U,$J,358.3,30858,0)
;;=N13.2^^123^1596^10
;;^UTILITY(U,$J,358.3,30858,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30858,1,3,0)
;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction
;;^UTILITY(U,$J,358.3,30858,1,4,0)
;;=4^N13.2
;;^UTILITY(U,$J,358.3,30858,2)
;;=^5015577
;;^UTILITY(U,$J,358.3,30859,0)
;;=N13.30^^123^1596^13
;;^UTILITY(U,$J,358.3,30859,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30859,1,3,0)
;;=3^Hydronephrosis,Unspec
;;^UTILITY(U,$J,358.3,30859,1,4,0)
;;=4^N13.30
;;^UTILITY(U,$J,358.3,30859,2)
;;=^5015578
;;^UTILITY(U,$J,358.3,30860,0)
;;=N13.39^^123^1596^12
;;^UTILITY(U,$J,358.3,30860,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,30860,1,3,0)
;;=3^Hydronephrosis,Other
;;^UTILITY(U,$J,358.3,30860,1,4,0)
;;=4^N13.39
;;^UTILITY(U,$J,358.3,30860,2)
;;=^5015579
;;^UTILITY(U,$J,358.3,30861,0)
;;=R33.9^^123^1596^16
;;^UTILITY(U,$J,358.3,30861,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1XL 3770 printed Apr 09, 2024@21:33:35 Page 2
IBDEI1XL ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,30848,2)
+2 ;;=^5063033
+3 ;;^UTILITY(U,$J,358.3,30849,0)
+4 ;;=N17.0^^123^1596^3
+5 ;;^UTILITY(U,$J,358.3,30849,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,30849,1,3,0)
+8 ;;=3^AKI w/ Tubular Necrosis
+9 ;;^UTILITY(U,$J,358.3,30849,1,4,0)
+10 ;;=4^N17.0
+11 ;;^UTILITY(U,$J,358.3,30849,2)
+12 ;;=^5015598
+13 ;;^UTILITY(U,$J,358.3,30850,0)
+14 ;;=N17.1^^123^1596^1
+15 ;;^UTILITY(U,$J,358.3,30850,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,30850,1,3,0)
+18 ;;=3^AKI w/ Acute Cortical Necrosis
+19 ;;^UTILITY(U,$J,358.3,30850,1,4,0)
+20 ;;=4^N17.1
+21 ;;^UTILITY(U,$J,358.3,30850,2)
+22 ;;=^5015599
+23 ;;^UTILITY(U,$J,358.3,30851,0)
+24 ;;=N17.2^^123^1596^2
+25 ;;^UTILITY(U,$J,358.3,30851,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,30851,1,3,0)
+28 ;;=3^AKI w/ Medullary Necrosis
+29 ;;^UTILITY(U,$J,358.3,30851,1,4,0)
+30 ;;=4^N17.2
+31 ;;^UTILITY(U,$J,358.3,30851,2)
+32 ;;=^5015600
+33 ;;^UTILITY(U,$J,358.3,30852,0)
+34 ;;=N10.^^123^1596^6
+35 ;;^UTILITY(U,$J,358.3,30852,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,30852,1,3,0)
+38 ;;=3^Acute Tubulo-Interstitial Nephritis
+39 ;;^UTILITY(U,$J,358.3,30852,1,4,0)
+40 ;;=4^N10.
+41 ;;^UTILITY(U,$J,358.3,30852,2)
+42 ;;=^5015570
+43 ;;^UTILITY(U,$J,358.3,30853,0)
+44 ;;=N17.8^^123^1596^4
+45 ;;^UTILITY(U,$J,358.3,30853,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,30853,1,3,0)
+48 ;;=3^AKI,Other
+49 ;;^UTILITY(U,$J,358.3,30853,1,4,0)
+50 ;;=4^N17.8
+51 ;;^UTILITY(U,$J,358.3,30853,2)
+52 ;;=^5015601
+53 ;;^UTILITY(U,$J,358.3,30854,0)
+54 ;;=N17.9^^123^1596^5
+55 ;;^UTILITY(U,$J,358.3,30854,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,30854,1,3,0)
+58 ;;=3^AKI,Unspec
+59 ;;^UTILITY(U,$J,358.3,30854,1,4,0)
+60 ;;=4^N17.9
+61 ;;^UTILITY(U,$J,358.3,30854,2)
+62 ;;=^338532
+63 ;;^UTILITY(U,$J,358.3,30855,0)
+64 ;;=R39.2^^123^1596^15
+65 ;;^UTILITY(U,$J,358.3,30855,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,30855,1,3,0)
+68 ;;=3^Pre-Renal Uremia
+69 ;;^UTILITY(U,$J,358.3,30855,1,4,0)
+70 ;;=4^R39.2
+71 ;;^UTILITY(U,$J,358.3,30855,2)
+72 ;;=^5019348
+73 ;;^UTILITY(U,$J,358.3,30856,0)
+74 ;;=N13.9^^123^1596^14
+75 ;;^UTILITY(U,$J,358.3,30856,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,30856,1,3,0)
+78 ;;=3^Obstructive and Reflux Uropathy,Unspec
+79 ;;^UTILITY(U,$J,358.3,30856,1,4,0)
+80 ;;=4^N13.9
+81 ;;^UTILITY(U,$J,358.3,30856,2)
+82 ;;=^5015589
+83 ;;^UTILITY(U,$J,358.3,30857,0)
+84 ;;=N13.1^^123^1596^11
+85 ;;^UTILITY(U,$J,358.3,30857,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,30857,1,3,0)
+88 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC
+89 ;;^UTILITY(U,$J,358.3,30857,1,4,0)
+90 ;;=4^N13.1
+91 ;;^UTILITY(U,$J,358.3,30857,2)
+92 ;;=^5015576
+93 ;;^UTILITY(U,$J,358.3,30858,0)
+94 ;;=N13.2^^123^1596^10
+95 ;;^UTILITY(U,$J,358.3,30858,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,30858,1,3,0)
+98 ;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction
+99 ;;^UTILITY(U,$J,358.3,30858,1,4,0)
+100 ;;=4^N13.2
+101 ;;^UTILITY(U,$J,358.3,30858,2)
+102 ;;=^5015577
+103 ;;^UTILITY(U,$J,358.3,30859,0)
+104 ;;=N13.30^^123^1596^13
+105 ;;^UTILITY(U,$J,358.3,30859,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,30859,1,3,0)
+108 ;;=3^Hydronephrosis,Unspec
+109 ;;^UTILITY(U,$J,358.3,30859,1,4,0)
+110 ;;=4^N13.30
+111 ;;^UTILITY(U,$J,358.3,30859,2)
+112 ;;=^5015578
+113 ;;^UTILITY(U,$J,358.3,30860,0)
+114 ;;=N13.39^^123^1596^12
+115 ;;^UTILITY(U,$J,358.3,30860,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,30860,1,3,0)
+118 ;;=3^Hydronephrosis,Other
+119 ;;^UTILITY(U,$J,358.3,30860,1,4,0)
+120 ;;=4^N13.39
+121 ;;^UTILITY(U,$J,358.3,30860,2)
+122 ;;=^5015579
+123 ;;^UTILITY(U,$J,358.3,30861,0)
+124 ;;=R33.9^^123^1596^16
+125 ;;^UTILITY(U,$J,358.3,30861,1,0)
+126 ;;=^358.31IA^4^2
